 | Up a level |
Ghasempour, Ghasem; Zamani-Garmsiri, Fahimeh; Farhad, Shaikhnia; Soleimani, Ali; Hosseini Fard, Syed Reza; Leila, Janani; Teimuri, Shohreh; Parvaz, Najmeh; Mohammadi, Payam; Najafi, Mohammad (2024). Efficacy and Safety of Alirocumab and Evolocumab as Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors in Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis. Current medicinal chemistry, 31(2), pp. 223-241. Bentham 10.2174/0929867330666230228120601
Yenkoyan, Konstantin; Ounanian, Zadik; Mirumyan, Margarita; Hayrapetyan, Liana; Zakaryan, Naira; Sahakyan, Raisa; Bjørklund, Geir (2024). Advances in the Treatment of Autism Spectrum Disorder: Current and Promising Strategies. Current medicinal chemistry, 31(12), pp. 1485-1511. Bentham 10.2174/0109298673252910230920151332
Gencer, Baris; Mach, François (2022). PCSK9 Inhibition could be Effective for Acute Myocardial Infarction. Current medicinal chemistry, 29(6), pp. 1016-1026. Bentham 10.2174/0929867328666210804091003
Fiaschetti, G; Grotzer, M A; Shalaby, T; Castelletti, D; Arcaro, A (2011). Quassinoids: From traditional drugs to new cancer therapeutics. Current medicinal chemistry, 18(3), pp. 316-28. Schiphol: Bentham 10.2174/092986711794839205
